David Grainger is a partner at Index Ventures, a global venture capital firm with offices in London, Geneva and San Francisco, in the firm’s life sciences practice. He is also a partner at TCP Innovations, a life sciences consultancy, and a blogger on topics related to the pharmaceutical industry under the pen name “DrugBaron”.